Aktuelle Veranstaltungen

Dear colleagues,

We are pleased to invite you to a lecture of the Heidelberg Frontiers in Medicine Lecture Series, taking place on June 26, 2025, and to be delivered by 

Prof. Dr. Huda Zoghbi, MD,
Investigator, Howard Hughes Medical Institute
Director, Jan and Dan Duncan Neurological Research Institute 
at Texas Children's Hospital
Distinguished Service Professor, Baylor College of Medicine

 Lecture details:
Date: Thursday, June 26, 2025, 
16:00-17.00: Talk :‘Rett syndrome and MECP2 disorders from the clinic to the bench and back’ 
Venue: Lecture Hall, Marsilius Kolleg, Im Neuenheimer Feld 130.1, 69120 Heidelberg
17.00-18.00: Post-lecture reception with the speaker for all attendees 
Venue: Foyer, Marsilius Kolleg, Im Neuenheimer Feld 130.1, 69120 Heidelberg 

About the speaker:

Huda Zoghbi is Professor of Pediatrics, Molecular and Human Genetics, Neuroscience and Neurology at Baylor College of Medicine. She has been bestowed with a large number of highly prestigious international awards, including the Breakthrough Prize in Life Science, the Canada Gairdner International Award, the Gruber Prize in Neuroscience, the Kavli Prize in Neuroscience, the Brain Prize, the Shaw Prize in Life Science and Medicine, and many others others.
Dr. Zoghbi trained in pediatrics and molecular genetics at Baylor College of Medicine. Her primary research interest spans the areas of neurodevelopment and neurodegeneration: Of note is her  pioneering discovery that Spinocerebellar ataxia type 1 is caused by polyglutamine expansion.
Her work on toxic protein accumulation provided broader insights into Alzheimer disease and related disorders. She identified key tau regulators, that opened up novel therapeutic avenues. In neurodevelopment, she discovered the Math1/Atoh1 gene, which plays a critical role in the development of sensory and respiratory circuits.
Her identification of MECP2 mutations as the of Rett syndrome has paved the way for the development of various genetic and antisense therapies. Dr. Zoghbi has been a dedicated mentor to over 110 young scientists. She is a member of numerous boards, including the Board of Trustees at Rockefeller University, the Scientific Advisory Board of the Chan-Zuckerberg Initiative, as well as the Board of Directors of theThe McKnight Endowment Fund for Neuroscience, to name but a few.

• Prof. Dr. Huda Zoghbi, Texas Children's Hospital
• Prof. Dr. Huda Zoghbi, Baylor College of Medicine

Dear colleagues,

We would like to invite you to a lecture in the Heidelberg Frontiers in Medicine Lecture Series on January 15, 2025 by

Prof. Dr. Mathias Lichterfeld, MD PhD
Professor of Medicine, Harvard Medical School
Harvard University Center for AIDS Research (CFAR)
Director,  CFAR Program in HIV Eradication 

Lecture details: 

Date and venue: January 15, 2025, Surgery Clinic, Im Neuenheimer Feld 420
16:00-17.00: Talk titled ‘Recent advances in finding a cure for HIV infection’ 
17.00-18.00: Reception with the speaker for all attendees in the foyer 

About the speaker:

Prof. Lichterfeld is an expert on infectious diseases with a focus on retroviral infections, particularly HIV-1. His research group explores the mechanisms underlying HIV-1 persistence in the human body using new technologies, such as single-cell profiling of virally-infected cells.

Prof. Lichterfeld also leads clinical trials on HIV eradication and cure, and is a staff physician at Brigham and Women’s Hospital (BWH) and MGH at Harvard Medical School. He is a member of the Ragon Institute and an Associate Member of the Broad Institute of MIT and Harvard. Prof. Lichterfeld received his medical degree from Heidelberg University and completed his medical specialization at the Massachusetts General Hospital.

• Poster